Metropolitan Life Insurance Company (MetLife)’s Lam Research LRCX Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio LRCX Stock Details LRCX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-52,890	Closed	-$5.14M	–	1200
2024 Q1	$5.14M	Sell	52,890 -760	-1%	-$66.9K	0.22%	78
2023 Q4	$4.2M	Sell	53,650 -1,510	-3%	-$103K	0.2%	92
2023 Q3	$3.46M	Sell	55,160 -3,390	-6%	-$223K	0.18%	102
2023 Q2	$3.76M	Sell	58,550 -1,810	-3%	-$102K	0.18%	100
2023 Q1	$3.2M	Sell	60,360 -15,330	-20%	-$752K	0.16%	115
2022 Q4	$3.18M	Sell	75,690 -2,970	-4%	-$124K	0.14%	142
2022 Q3	$2.88M	Sell	78,660 -1,980	-2%	-$88.1K	0.14%	145
2022 Q2	$3.44M	Sell	80,640 -2,520	-3%	-$120K	0.15%	134
2022 Q1	$4.47M	Sell	83,160 -140,430	-63%	-$8.17M	0.16%	121
2021 Q4	$16.1M	Sell	223,590 -8,190	-4%	-$513K	0.22%	75
2021 Q3	$13.2M	Sell	231,780 -247,880	-52%	-$15.1M	0.19%	93
2021 Q2	$31.2M	Buy	479,660 +231,710	+93%	+$14.6M	0.22%	82
2021 Q1	$14.8M	Sell	247,950 -17,300	-7%	-$943K	0.22%	80
2020 Q4	$12.5M	Sell	265,250 -12,290	-4%	-$517K	0.19%	88
2020 Q3	$9.21M	Sell	277,540 -10,720	-4%	-$369K	0.16%	109
2020 Q2	$9.32M	Buy	288,260 +14,880	+5%	+$406K	0.17%	107
2020 Q1	$6.56M	Sell	273,380 -3,640	-1%	-$105K	0.13%	143
2019 Q4	$8.1M	Sell	277,020 -4,740	-2%	-$126K	0.13%	141
2019 Q3	$6.51M	Sell	281,760 -20,830	-7%	-$437K	0.11%	160
2019 Q2	$5.68M	Buy	302,590 +8,540	+3%	+$162K	0.1%	186
2019 Q1	$5.26M	Sell	294,050 -12,730	-4%	-$212K	0.1%	185
2018 Q4	$4.18M	Sell	306,780 -1,790	-0.6%	-$25.7K	0.08%	200
2018 Q3	$4.68M	Sell	308,570 -20,090	-6%	-$343K	0.08%	210
2018 Q2	$5.68M	Buy	328,660 +4,630	+1%	+$89.2K	0.09%	189
2018 Q1	$6.58M	Buy	324,030 +3,920	+1%	+$77.6K	0.09%	174
2017 Q4	$5.89M	Sell	320,110 -519,280	-62%	-$10.2M	0.08%	186
2017 Q3	$15.5M	Sell	839,390 -5,550	-0.7%	-$90.1K	0.1%	184
2017 Q2	$11.9M	Sell	844,940 -7,200	-0.8%	-$106K	0.08%	229
2017 Q1	$10.9M	Sell	852,140 -11,850	-1%	-$139K	0.08%	244
2016 Q4	$9.13M	Sell	863,990 -11,290	-1%	-$115K	0.07%	278
2016 Q3	$8.29M	Sell	875,280 -6,820	-0.8%	-$62.1K	0.06%	297
2016 Q2	$7.42M	Buy	882,100 +2,080	+0.2%	+$16.7K	0.06%	332
2016 Q1	$7.27M	Sell	880,020 -9,630	-1%	-$70K	0.06%	331
2015 Q4	$7.07M	Sell	889,650 -11,010	-1%	-$82.8K	0.05%	330
2015 Q3	$5.88M	Sell	900,660 -16,510	-2%	-$121K	0.04%	424
2015 Q2	$7.46M	Buy	917,170 +26,800	+3%	+$210K	0.05%	358
2015 Q1	$6.25M	Sell	890,370 -9,830	-1%	-$77.7K	0.05%	423
2014 Q4	$7.14M	Sell	900,200 -33,910	-4%	-$263K	0.05%	368
2014 Q3	$6.98M	Sell	934,110 -14,300	-2%	-$102K	0.05%	364
2014 Q2	$6.41M	Sell	948,410 -44,980	-5%	-$269K	0.04%	418
2014 Q1	$5.46M	Sell	993,390 -15,960	-2%	-$84.8K	0.04%	491
2013 Q4	$5.5M	Sell	1,009,350 -22,680	-2%	-$119K	0.04%	474
2013 Q3	$5.28M	Sell	1,032,030 -3,550	-0.3%	-$17.4K	0.04%	464
2013 Q2	$4.59M	Buy	+1,035,580	New	+$4.68M	0.04%	482

Other funds holding LRCX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s LRCX Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Lam Research (LRCX) in Q2 2024, closing a stake of 52,890 shares — an estimated $5.14M sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in LRCX in Q2 2013 and held it in 44 quarters. The position peaked at $31.2M in Q2 2021. 1,793 funds tracked by Wall St. Rank hold LRCX as of Q2 2024.

Metropolitan Life Insurance Company (MetLife) reported no remaining Lam Research position as of Q2 2024 after selling out during the quarter.
Metropolitan Life Insurance Company (MetLife) sold 52,890 Lam Research shares in Q2 2024, an estimated $5.14M.
Metropolitan Life Insurance Company (MetLife) first reported a position in Lam Research in Q2 2013 and held it in 44 quarters.
Metropolitan Life Insurance Company (MetLife)'s Lam Research position peaked at $31.2M in Q2 2021.
1,793 funds tracked by Wall St. Rank held Lam Research as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.